
结论很明确:这个市场不适合进入,已经接近价格战,并且对小商家和跨品类大品牌都不友好。 现有新品牌只有5个,其中真正盈利的新品牌新品只有1个,成功率16.67%;而新品牌自己的新品成功率也是20%,失败占80%,说明现在不是“容易赚钱”的窗口,而是“靠更强品牌力和更高投入硬挤”的市场。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很直接:这不是适合现在进入的市场。 你的预算是50万人民币,但能参考的盈利样本里,真正撑得住的只有“头部品牌+高辨识度差异化”路线;对小商家来说,市场已经明显偏向价格战和品牌战,50万只能覆盖前期上架与投放,撑不起长期研发、品牌和认证成本。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入,已经明显偏向价格战和高门槛竞争。 新品牌虽然有成功样本,但成功率不够稳,失败样本更集中;对小品牌来说,低价段已经被压到亏损区,想硬进大概率只能靠重营销甚至更激进打法。
这个市场不值得进入,已经接近/进入价格战与过度拥挤状态;小品牌不应贸然进场,大品牌也不该把它当成低风险扩张。 现有样本里,整体可判定盈利的只有25%,新上架产品里仅16.67%盈利,而且新品牌新上架产品里盈利的只看到1个(medicube),其余4个新品牌新上架产品全部亏损或未起量,说明新进入者大概率先被打穿。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0FPQGLYK9 | medicube | 2026-03-10 | Yes | £16.59 | 6000pcs | £99540.0 | 14.1% | £14035.14 |
![]() | B0DZ36BRDR | Supergoop! | 2025-03-03 | Yes | £14.02 | 50pcs | £701.0 | 17.67% | £123.87 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FPQGLYK9 | medicube | 2026-03-10 | Yes | £16.59 | 6000pcs | £99540.0 | 14.1% | £14035.14 |
结论很明确:这个市场不适合进入,已经进入高竞争、接近价格战的状态。 现有数据里,新产品成功率只有16.67%,而新品牌自身的成功率也只有20%,失败占80%;更关键的是,4个新品牌新产品全部失败,只有 medicube 这一家新品牌拿到1个盈利款,说明成功高度集中、复制难度很高。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场不值得进入,已经进入高竞争、接近价格战的状态。 近期香港样本里新品牌新品成功率只有20%,失败率80%,而最近新增里4个新品牌新品全部不盈利,只有 medicube 的 B0FPQGLYK9 例外;这说明现在不是“容易赚钱”的窗口,而是“靠更大预算和更强品牌力硬挤”的市场。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |